|
Dr. Manuso is currently Chairman President and CEO of SuperGen Inc. (NASDAQ: SUPG) and has served as a SuperGen Director since February 2001. He was a co-founder and immediate past President and CEO of Galenica Pharmaceuticals Inc. Dr. Manuso co-founded and was general partner of PrimeTech Partners a biotechnology venture management partnership from 1998 to 2002 and Managing General Partner of The Channel Group LLC an international life sciences corporate advisory firm. He was also President of Manuso Alexander & Associates Inc. management consultants and financial advisors to pharmaceutical and biotechnology companies. Dr. Manuso was a Vice President and Director of Health Care Planning and Development for The Equitable Companies (now Group Axa) where he also served as Acting Medical Director. He currently serves on the boards of privately-held KineMed Inc. and Merrion Pharmaceuticals Ltd. (Dublin Ireland). Previously he co-founded and served as Vice Chairman and Chief Business Officer of ZyStor Therapeutics and he served on the boards of Quark Inflazyme Supratek Pharma and other companies. Dr. Manuso earned a B.A. with Honors in Economics and Chemistry from New York University a Ph.D. in Experimental Psychophysiology from the Graduate Faculty of The New School University a Certificate in Health Systems Management from Harvard Business School and an Executive M.B.A. from Columbia Business School. He is the author of over 30 chapters articles and books on topics including health care cost containment and biotechnology company management. Dr. Manuso has taught and lectured at Columbia New York University Georgetown Polytechnic University and Waseda University (Japan) and he has delivered addresses at a multitude of professional and financial conferences throughout the world. | 